CDC RSV Pregnancy Recommendations and Vaccine Options
The CDC recommends RSV vaccination during pregnancy to protect newborns, with the maternal RSV vaccine, Abrysvo by Pfizer, authorized for use in individuals aged 32 through 36 weeks of gestation, typically administered between September and January. The CDC's Advisory Committee on Immunization Practices (ACIP) issued this guidance to reduce severe RSV outcomes in infants during their first months of life, aligning with broader maternal immunization strategies. For details on the official CDC RSV vaccine recommendations, see the CDC RSV Vaccine page.
Abrysvo is a single-dose vaccine given during the third trimester, and clinical data show it significantly lowers the risk of severe RSV disease in infants from birth through 6 months. The CDC emphasizes that vaccination should be offered to pregnant individuals who are or will be during the RSV season, and coverage depends on insurance status and health plan policies. The CDC also notes that maternal RSV vaccination complements, but does not replace, other preventive measures like maternal flu shots and infant RSV immunoprophylaxis.
RSV Risks During Pregnancy and Infant Outcomes
RSV infection during pregnancy can lead to adverse outcomes including preterm birth and lower respiratory tract illness in the mother, and the CDC highlights that infants born during or shortly after RSV season face the highest risk of severe disease. The CDC's surveillance data show that RSV is a leading cause of hospitalization in young children, and maternal vaccination is a key tool to reduce infant hospitalizations. For context on RSV burden and CDC tracking, see the CDC RSV Surveillance page.
Severe RSV in infants can cause bronchiolitis and pneumonia, and the CDC notes that premature infants and those with certain underlying conditions are at elevated risk. The CDC's guidance also references the use of long-acting monoclonal antibodies like Beyfortus (nirsevimab) for infants, which provides direct protection when maternal vaccination is not administered or is insufficient. The CDC advises that pregnant individuals discuss RSV prevention with their healthcare provider to weigh individual risk factors and timing.
Insurance Coverage and Access to RSV Vaccines for Pregnant Individuals
Under the Affordable Care Act, most private health plans must cover CDC-recommended vaccines, including Abrysvo, without cost-sharing when administered in-network, and the CDC's vaccine coverage guidance applies to pregnancy-related immunizations. The CDC also notes that Medicaid and CHIP typically cover RSV vaccines for eligible pregnant individuals, and access may vary by state and plan. For details on CDC vaccine coverage rules, see the CDC Vaccine Coverage page.
Pharmacy chains such as CVS, Walgreens, and Walmart offer CDC-recommended vaccines, including RSV shots during pregnancy, and many provide online scheduling and insurance verification tools. The CDC's VaccineFinder tool helps locate in-network providers, and the CDC advises checking plan benefits for any prior authorization requirements. For more on CDC vaccine access and pharmacy programs, see the CDC VaccineFinder page.